Posted Feb. 7, 2012 at 6:19 a.m.

Premium Lock Startup Chimerix reports positive test news for transplant drug

Published: 2012-02-07 06:19:23
Updated: 2012-02-07 06:19:23

Chimerix Chimerix

The company is studying the compound for the prevention of cytomegalovirus diseases, or CMV, in patients who have had stem cell transplants....

Read More
Read More

Copyright 2017 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders